6C47.4

ICD-11 MMS 2026-01

Synthetic cathinone withdrawal

Description

Synthetic cathinone withdrawal is a clinically significant cluster of symptoms, behaviours and/or physiological features, varying in degree of severity and duration, that occurs upon cessation or reduction of use of synthetic cathinones in individuals who have developed Synthetic cathinone dependence or have used synthetic cathinones for a prolonged period or in large amounts. Presenting features of Synthetic cathinone withdrawal may include dysphoric mood, irritability, fatigue, insomnia or (more commonly) hypersomnia, vivid and unpleasant dreams, increased appetite, psychomotor agitation or retardation, and craving for stimulants, including synthetic cathinones.

Index terms

  • Synthetic cathinone withdrawal

Exclusions from above levels

  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C47.0 – Episode of harmful use of synthetic cathinones
  • 6C47.1 – Harmful pattern of use of synthetic cathinones
  • 6C47.2 – Synthetic cathinone dependence
  • 6C47.3 – Synthetic cathinone intoxication
  • 6C47.5 – Synthetic cathinone-induced delirium
  • 6C47.6 – Synthetic cathinone-induced psychotic disorder
  • 6C47.7 – Certain specified synthetic cathinone-induced mental or behavioural disorders
  • 6C47.Y – Other specified disorders due to use of synthetic cathinones
  • 6C47.Z – Disorders due to use of synthetic cathinones, unspecified

Foundation entity

Synthetic cathinone withdrawal – http://id.who.int/icd/entity/1587633989

Allowed postcoordination axes

Part of: 6C47: Disorders due to use of synthetic cathinones › 06: Mental, behavioural or neurodevelopmental disorders